Alnylam Pharmaceuticals, Inc.

Lansforsakringar Fondforvaltning AB (publ) ALNY

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/23/2026

Shares

41,890

Value ($000)

13,860

Weight

0.1%

2024 Q4 - 2026 Q1 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/23/2026	13,860	0.1%	41,890	3/31/2026
2025 Q4	2/12/2026	16,837	0.1%	42,340	12/31/2025
2025 Q3	11/10/2025	19,336	0.1%	42,404	9/30/2025
2025 Q2	8/13/2025	13,119	0.1%	40,231	6/30/2025
2025 Q1	5/14/2025	11,423	0.1%	42,303	3/31/2025
2024 Q4	3/14/2025	10,011	0.1%	42,544	12/31/2024